SCHEMBL17834788

SCHEMBL17834788

CC[C@H]1CC[C@H](c2ccc(-c3cnc(-c4ccc(C[C@H](NC(=O)c5ccc(C(C)(C)C)cc5)C(=O)O)cc4)nc3)cc2)CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ DGAT1 O75907 1/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ MAPT P10636 2/20 0.39
▸ LMNA P02545 1/20 0.39
▸ ITGB1 P05556 3/20 0.39
▸ ITGA4 P13612 2/20 0.39
▸ PDK1 Q15118 1/20 0.38
▸ PDK2 Q15119 1/20 0.38
▸ PDK3 Q15120 1/20 0.38
▸ PDK4 Q16654 1/20 0.38
▸ PTPN1 P18031 2/20 0.38
▸ MME P08473 1/20 0.38
▸ ACE P12821 1/20 0.38
▸ ACE2 Q9BYF1 1/20 0.38
▸ CETP P11597 1/20 0.37
▸ ITGB3 P05106 1/20 0.37
▸ ITGAV P06756 1/20 0.37
▸ ITGA2B P08514 1/20 0.37
▸ ITGA5 P08648 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17834678 0.93 ALDH1A1 (0.38) L3MBTL1DGAT1ALDH1A1MAPTLMNA
SCHEMBL17834644 0.92 KIFC1 (0.43) L3MBTL1DGAT1ALDH1A1MAPTLMNA
SCHEMBL17834635 0.92 ITGB1 (0.40) L3MBTL1DGAT1ALDH1A1MAPTLMNA
SCHEMBL17834669 0.91 DGAT1 (0.41) L3MBTL1DGAT1ALDH1A1MAPTLMNA
SCHEMBL17834643 0.91 ITGB1 (0.40) L3MBTL1DGAT1ALDH1A1MAPTLMNA
SCHEMBL17834638 0.91 ITGB1 (0.40) L3MBTL1DGAT1ALDH1A1MAPTLMNA
SCHEMBL17834790 0.91 ITGB1 (0.37) DGAT1ALDH1A1MAPTLMNAITGB1
SCHEMBL17834791 0.91 MME (0.38) DGAT1ALDH1A1MAPTLMNAITGB1
SCHEMBL17834624 0.91 L3MBTL1 (0.41) L3MBTL1DGAT1ALDH1A1MAPTLMNA
SCHEMBL17995135 0.91 CA2 (0.46) DGAT1ITGB1ITGA4PTPN1GPR132

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10034886-B2 GLP-1 receptor modulators CELGENE INTERNATIONAL II SÀRL (CH) 2018-07-31 — — US disclosed
US-10034886-B2 GLP-1 receptor modulators CELGENE INTERNATIONAL II SÀRL (CH) 2018-07-31 — — US disclosed
US-20180021346-A1 NOVEL GLP-1 RECEPTOR MODULATORS RECEPTOS LLC 2018-01-25 — — US disclosed
US-9795613-B2 GLP-1 receptor modulators CELGENE INTERNATIONAL II SÀRL (CH) 2017-10-24 — — US disclosed
US-9795613-B2 GLP-1 receptor modulators CELGENE INTERNATIONAL II SÀRL (CH) 2017-10-24 — — US disclosed
US-20160228450-A1 NOVEL GLP-1 RECEPTOR MODULATORS RECEPTOS LLC 2016-08-11 — — US disclosed
WO-2016094729-A1 GLP-1 RECEPTOR MODULATORS CELGENE INTERNATIONAL II SARL (CH) 2016-06-16 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160228450-A1 NOVEL GLP-1 RECEPTOR MODULATORS GLP1R, GIPR, NPY1R L3MBTL1 771/4885DGAT1 2899/4885ALDH1A1 4770/4885
US-20180021346-A1 NOVEL GLP-1 RECEPTOR MODULATORS GLP1R, GIPR, NPY1R L3MBTL1 771/4885DGAT1 2899/4885ALDH1A1 4770/4885
US-10034886-B2 GLP-1 receptor modulators GLP1R, GIPR, GCGR L3MBTL1 579/4885DGAT1 2729/4885ALDH1A1 4737/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback